Correspondence 0001193125-26-009092 from CERENOME, INC. (PSTV)
CERENOME, INC.
Date: Jan. 9, 2026 · CIK: 0001095981 · Accession: 0001193125-26-009092
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-292637
Letter
January 9, 2026 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Plus Therapeutics, Inc. Registration Statement on Form S-1 filed on January 9, 2026 File No. 333-292637 Request for Acceleration of Effective Date Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Plus Therapeutics, Inc. hereby requests for acceleration of the effective date of the above-referenced registration statement so that it becomes effective as of 5:00 p.m. Eastern Time on Tuesday, January 13, 2026, or as soon thereafter as possible. [Signature Page to Follow]
Very truly yours,
Plus Therapeutics, Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP January 9, 2026 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Plus Therapeutics, Inc. Registration Statement on Form S-1 filed on January 9, 2026 File No. 333-292637 Request for Acceleration of Effective Date Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Plus Therapeutics, Inc. hereby requests for acceleration of the effective date of the above-referenced registration statement so that it becomes effective as of 5:00 p.m. Eastern Time on Tuesday, January 13, 2026, or as soon thereafter as possible. [Signature Page to Follow] Very truly yours, Plus Therapeutics, Inc. By: /s/ Andrew Sims Name: Andrew Sims Title: Chief Financial Officer cc: Aaron M. Schleicher, Sullivan & Worcester LLP [Signature Page to Acceleration Request]